AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 47 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $21,000 | +31.2% | 33,288 | +79.7% | 0.00% | – |
| Q3 2019 | $16,000 | +1500.0% | 18,529 | +726.4% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 2,242 | +12.1% | 0.00% | – |
| Q1 2019 | $2,000 | -97.6% | 2,000 | -96.2% | 0.00% | – |
| Q4 2018 | $84,000 | -67.7% | 52,842 | -32.7% | 0.00% | – |
| Q3 2018 | $260,000 | +101.6% | 78,547 | +37.0% | 0.00% | – |
| Q2 2018 | $129,000 | – | 57,340 | +57240.0% | 0.00% | – |
| Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 100 | -99.4% | 0.00% | – |
| Q3 2017 | $57,000 | – | 15,677 | +15577.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 100 | -91.8% | 0.00% | – |
| Q1 2017 | $1,000 | – | 1,215 | +440.0% | 0.00% | – |
| Q4 2016 | $0 | – | 225 | -45.8% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 415 | -95.9% | 0.00% | – |
| Q2 2016 | $10,000 | +900.0% | 10,030 | +1571.7% | 0.00% | – |
| Q1 2016 | $1,000 | -93.8% | 600 | -95.1% | 0.00% | – |
| Q4 2015 | $16,000 | -23.8% | 12,183 | -28.6% | 0.00% | – |
| Q3 2015 | $21,000 | +50.0% | 17,070 | +109.9% | 0.00% | – |
| Q2 2015 | $14,000 | +250.0% | 8,131 | +147.1% | 0.00% | – |
| Q1 2015 | $4,000 | -85.2% | 3,291 | -89.7% | 0.00% | – |
| Q4 2014 | $27,000 | – | 32,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |